The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients With Critical COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled Trial*

Overview of attention for article published in Critical Care Medicine, August 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

blogs: 1 blog
twitter: 63 X users
patent: 1 patent
facebook: 1 Facebook page

reddit: 3 Redditors
video: 1 YouTube creator
bluesky: 2 Bluesky users
podcasts: 1 podcast

Readers on

mendeley: 42 Mendeley

So far, Altmetric has seen 81 X posts from 63 X users, with an upper bound of 343,276 followers.

https://t.co/MFlWYHaQc1

RT @TunesOnX: @SarahGeving1 Or #Aviptadil - a natural peptide produced by the body like Insulin - discovered 50 years ago and tested on mul…

@SarahGeving1 Or #Aviptadil - a natural peptide produced by the body like Insulin - discovered 50 years ago and tested on multiple mammals with immaculate safety records It's what India uses today....but our @US_FDA shut it down because it doesn't prof…

RT @FiloSofoClez: #CestFini #GameOverCovid Chau #plandemia. El uso de péptido intestinal vasoactivo intravenoso (aviptadil) (de manera exit…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 77 additional X posts.